Kalif Eliyahu Sharon (CIK 1798443) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-16). Recent activity: Sell TEVA (106,563 shares), Sell TEVA (153,251 shares), Buy TEVA (19,916 shares), Buy TEVA (33,512 shares), Buy TEVA (23,251 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Sell | 106,563 | $3.6M |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Sell | 153,251 | $5.5M |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Buy | 19,916 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Buy | 33,512 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Buy | 23,251 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Buy | 49,800 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Buy | 141,478 | $0 |
| 2026-03-02 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Sell | 345,810 | $11.6M |
| 2025-06-16 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | Sell | 55,775 | $952,637 |
来源：SEC Form 4 申报文件 · 截至 2026-06-16